68
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Chemoinformatics for Medicinal Chemistry: In Silico Model to Enable the Discovery of Potent and Safer Anti-Cocci Agents

&
Pages 2013-2028 | Published online: 22 Dec 2014

References

  • Ryan KJ . Streptococci and Enterococci. In : Sherris Medical Microbiology: An Introduction to Infectious Diseases.RyanKJ, RayCG ( Eds). McGraw-Hill Companies, Inc, London, UK, 273–296 (2004).
  • Brachman PS , AbrutynE. In : Bacterial Infections of Humans: Epidemiology and Control (4th Edition).Springer Science+Business Media, LLC, New York, NY, USA, (2009).
  • Paterson GK , HarrisonEM, CravenEFet al. Incidence and characterisation of methicillin-resistant Staphylococcus aureus (MRSA) from nasal colonisation in participants attending a cattle veterinary conference in the UK. PLoS ONE8 (7), e68463 (2013).
  • Vardakas KZ , KontopidisI, GkegkesID, RafailidisPI, FalagasME. Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a systematic review. Eur. J. Clin. Microbiol. Infect. Dis.32 (6), 711–721 (2013).
  • Silva-Costa C , FriaesA, RamirezM, Melo-CristinoJ. Differences between macrolide-resistant and -susceptible Streptococcus pyogenes: importance of clonal properties in addition to antibiotic consumption. Antimicrob. Agents Chemother.56 (11), 5661–5666 (2012).
  • Bidet P , LiguoriS, PlainvertCet al. Identification of group A streptococcal emm types commonly associated with invasive infections and antimicrobial resistance by the use of multiplex PCR and high-resolution melting analysis. Eur. J. Clin. Microbiol. Infect. Dis.31 (10), 2817–2826 (2012).
  • Arias CA , ContrerasGA, MurrayBE. Management of multi-drug resistant Enterococcal infections. Clin. Microbiol. Infect.16 (6), 555–562 (2010).
  • Printsevskaya SS , ReznikovaMI, KorolevAMet al. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles. Future Med. Chem.5 (6), 641–652 (2013).
  • Rigottier-Gois L , AlbertiA, HouelAet al. Large-scale screening of a targeted Enterococcus faecalis mutant library identifies envelope fitness factors. PLoS ONE6 (12), e29023 (2011).
  • Paul SM , MytelkaDS, DunwiddieCTet al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov.9 (3), 203–214 (2010).
  • Optimizing the ‘Drug-Like’ Properties of Leads in Drug Discovery. Borchardt RT , KernsEH, HagemanMJ, ThakkerDR, StevensJL ( Eds). Springer Science+Business Media, LLC, New York, NY, USA, (2006).
  • Croes S , KoopAH, van GilsSA, NeefC. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring. Eur. J. Pharm. Sci.45 (1–2), 90–100 (2012).
  • Hau J , SchapiroSJ. Handbook of Laboratory Animal Science: Essential Principles and Practices (3rd Edition).CRC Press, Taylor & Francis Group, LLC, Boca Raton, FL, USA, 1, (2011).
  • Todeschini R , ConsonniV. Molecular Descriptors for Chemoinformatics.WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, (2009).
  • Bunin BA , BajorathJ, SieselB, MoralesG. Chemoinformatics: Theory, Practice and Products.Springer, Dordrecht, Germany, (2007).
  • Oprea T . Chemoinformatics in Drug Discovery.WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 23, (2005).
  • Tenorio-Borroto E , Penuelas-RivasCG, Vasquez-ChagoyanJCet al. Model for high-throughput screening of drug immunotoxicity – study of the anti-microbial G1 over peritoneal macrophages using flow cytometry. Eur. J. Med. Chem.72, 206–220 (2014).
  • Tenorio-Borroto E , Garcia-MeraX, Penuelas-RivasCGet al. Entropy model for multiplex drug-target interaction endpoints of drug immunotoxicity. Curr. Top. Med. Chem.13 (14), 1636–1649 (2013).
  • Luan F , CordeiroMNDS, AlonsoNet al. TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases. Bioorg. Med. Chem.21 (7), 1870–1879 (2013).
  • Alonso N , CaamanoO, Romero-DuranFJet al. Model for high-throughput screening of multi-target drugs in chemical neurosciences; synthesis, assay and theoretic study of rasagiline carbamates. ACS Chem. Neurosci.4 (10), 1393–1403 (2013).
  • Tenorio-Borroto E , Penuelas RivasCG, Vasquez ChagoyanJCet al. ANN multiplexing model of drugs effect on macrophages: theoretical and flow cytometry study on the cytotoxicity of the anti-microbial drug G1 in spleen. Bioorg. Med. Chem.20 (20), 6181–6194 (2012).
  • Speck-Planche A , CordeiroMN. Simultaneous virtual prediction of anti-Escherichia coli activities and ADMET profiles: a chemoinformatic complementary approach for high-throughput screening. ACS Comb. Sci.16 (2), 78–84 (2014).
  • Speck-Planche A , KleandrovaVV, CordeiroMNDS. Chemoinformatics for rational discovery of safe antibacterial drugs: simultaneous predictions of biological activity against streptococci and toxicological profiles in laboratory animals. Bioorg. Med. Chem.21 (10), 2727–2732 (2013).
  • Speck-Planche A , KleandrovaVV, CordeiroMNDS. New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs. Eur. J. Pharm. Sci.48 (4–5), 812–818 (2013).
  • Speck-Planche A , CordeiroMNDS. Simultaneous modeling of antimycobacterial activities and ADMET profiles: a chemoinformatic approach to medicinal chemistry. Curr. Top. Med. Chem.13 (14), 1656–1665 (2013).
  • Speck-Planche A , CordeiroMNDS. Evolution of graph theory-based QSAR methods and their applications to the search for new antibacterial agents. Curr. Top. Med. Chem.13 (24), 3101–3117 (2013).
  • Gaulton A , BellisLJ, BentoAPet al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res.40 (Database issue), D1100–D1107 (2012).
  • Mok NY , BrenkR. Mining the ChEMBL database: an efficient chemoinformatics workflow for assembling an ion channel-focused screening library. J. Chem. Inf. Model.51 (10), 2449–2454 (2011).
  • Overington J . ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr. J. Comput. Aided Mol. Des.23 (4), 195–198 (2009).
  • EBI-Team: ChEMBL Database (2010). www.ebi.ac.uk/chembl
  • Estrada E . Spectral moments of the edge adjacency matrix in molecular graphs. I. Definition and applications for the prediction of physical properties of alkanes. J. Chem. Inf. Comput. Sci.36 (4), 844–849 (1996).
  • Estrada E . Spectral moments of the edge adjacency matrix in molecular graphs. II. Molecules containing heteroatoms and QSAR applications. J. Chem. Inf. Comput. Sci.37 (2), 320–328 (1997).
  • Estrada E . Spectral moments of the edge adjacency matrix in molecular graphs. III. Molecules containing cycles. J. Chem. Inf. Comput. Sci.38 (1), 23–27 (1998).
  • Estrada E , QuincocesJA, PatlewiczG. Creating molecular diversity from antioxidants in Brazilian propolis. Combination of TOPS-MODE QSAR and virtual structure generation. Mol. Divers.8 (1), 21–33 (2004).
  • Estrada E , UriarteE, MolinaE, Simon-MansoY, MilneGW. An integrated in silico analysis of drug-binding to human serum albumin. J. Chem. Inf. Model.46 (6), 2709–2724 (2006).
  • Morales Helguera A , Perez GonzalezM, CordeiroMNDS, Cabrera PerezMA. Quantitative structure-carcinogenicity relationship for detecting structural alerts in nitroso compounds: species, rat; sex, female; route of administration, gavage. Chem. Res. Toxicol.21 (3), 633–642 (2008).
  • Marzaro G , ChilinA, GuiottoAet al. Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors. Eur. J. Med. Chem.46 (6), 2185–2192 (2011).
  • Estrada E , PatlewiczG, ChamberlainM, BasketterD, LarbeyS. Computer-aided knowledge generation for understanding skin sensitization mechanisms: the TOPS-MODE approach. Chem. Res. Toxicol.16 (10), 1226–1235 (2003).
  • Vilar S , EstradaE, UriarteE, SantanaL, GutierrezY. In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. II. Purine derivatives. J. Chem. Inf. Model.45 (2), 502–514 (2005).
  • Estrada E , GutiérrezY. MODESLAB. (v1.5).Santiago de Compostela, Spain ( 2002–2004).
  • Hill T , LewickiP. STATISTICS Methods and Applications. In : A Comprehensive Reference for Science, Industry and Data Mining.StatSoft, Tulsa, OK, USA (2006).
  • Statsoft-Team . STATISTICA. Data analysis software system. (v6.0). Tulsa, OK, USA (2001).
  • Huberty CJ , OlejnikS. Applied MANOVA and discriminant analysis (2nd Edition).John Wiley & Sons, Inc., Hoboken, NJ, USA (2006).
  • Speck-Planche A , KleandrovaVV, LuanF, CordeiroMNDS. Rational drug design for anti-cancer chemotherapy: multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents. Bioorg. Med. Chem.20 (15), 4848–4855 (2012).
  • Hanczar B , HuaJ, SimaC, WeinsteinJ, BittnerM, DoughertyER. Small-sample precision of ROC-related estimates. Bioinformatics26 (6), 822–830 (2010).
  • Jurman G , RiccadonnaS, FurlanelloC. A comparison of MCC and CEN error measures in multi-class prediction. PLoS ONE7 (8), e41882 (2012).
  • Gonzalez-Diaz H , Herrera-IbataDM, Duardo-SanchezA, MunteanuCR, Orbegozo-MedinaRA, PazosA. ANN multiscale model of Anti-HIV drugs activity vs AIDS prevalence in the US at county level based on information indices of molecular graphs and social networks. J. Chem. Inf. Model.54 (3), 744–755 (2014).
  • Duardo-Sanchez A , MunteanuCR, Riera-FernandezP, Lopez-DiazA, PazosA, Gonzalez-DiazH. Modeling complex metabolic reactions, ecological systems, and financial and legal networks with MIANN models based on Markov-Wiener node descriptors. J. Chem. Inf. Model.54 (1), 16–29 (2013).
  • Estrada E , UriarteE, MonteroA, TeijeiraM, SantanaL, De ClercqE. A novel approach for the virtual screening and rational design of anticancer compounds. J. Med. Chem.43 (10), 1975–1985 (2000).
  • Estrada E , VilarS, UriarteE, GutierrezY. In silico studies toward the discovery of new anti-HIV nucleoside compounds with the use of TOPS-MODE and 2D/3D connectivity indices. 1. Pyrimidyl derivatives. J. Chem. Inf. Comput. Sci.42 (5), 1194–1203 (2002).
  • Speck-Planche A , KleandrovaVV, LuanF, CordeiroMNDS. Fragment-based QSAR model toward the selection of versatile anti-sarcoma leads. Eur. J. Med. Chem.46 (12), 5910–5916 (2011).
  • Prado-Prado FJ , Garcia-MeraX, Gonzalez-DiazH. Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorg. Med. Chem.18 (6), 2225–2231 (2010).
  • Helguera AM , GonzalezMP, CordeiroMNDS, PerezMA. Quantitative structure carcinogenicity relationship for detecting structural alerts in nitroso-compounds. Toxicol. Appl. Pharmacol.221 (2), 189–202 (2007).
  • Furiex Pharmaceuticals . (2014). www.furiex.com
  • Morrow BJ , HeW, AmslerKMet al. In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone. Antimicrob. Agents Chemother.54 (5), 1955–1964 (2010).
  • Fernandez J , HilliardJJ, MorrowBJet al. Efficacy of a new fluoroquinolone, JNJ-Q2, in murine models of Staphylococcus aureus and Streptococcus pneumoniae skin, respiratory, and systemic infections. Antimicrob. Agents Chemother.55 (12), 5522–5528 (2011).
  • Davenport JM , CovingtonP, GotfriedMet al. Summary of pharmacokinetics and tissue distribution of a broad-spectrum fluoroquinolone, JNJ-Q2. Clin. Pharmacol. Drug Dev.1 (4), 121–130 (2012).
  • Morrow BJ , AbbanatD, BaumEZet al. Antistaphylococcal activities of the new fluoroquinolone JNJ-Q2. Antimicrob. Agents Chemother.55 (12), 5512–5521 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.